Topchoice Medical Co Inc
Topchoice Medical Co Inc is a pharmaceutical company that generates revenue primarily through the production and sale of medical products and services.
Business. Topchoice Medical Co Inc (600763.SS) is a healthcare services and equipment company primarily engaged in pharmaceutical activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in China, the company is listed on the Shanghai Stock Exchange. Specific operating segments and geographic breakdowns are not disclosed in the available data.
Analyst recommendations
10 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Topchoice Medical Co Inc (600763.SS) is a healthcare services and equipment company primarily engaged in pharmaceutical activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in China, the company is listed on the Shanghai Stock Exchange. Specific operating segments and geographic breakdowns are not disclosed in the available data.
Topchoice Medical Co Inc maintains a strong capital structure with a debt-to-equity ratio of 0.26, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.49, suggesting it has sufficient short-term assets to cover its short-term liabilities, but not in excess. Free cash flow stands at 365.81 million CNY, which provides flexibility for reinvestment or shareholder returns.
Profitability metrics show that the company is performing well relative to industry standards. Return on equity (ROE) is 11.86%, and return on assets (ROA) is 8.31%, both of which are strong indicators of efficient use of equity and assets. These figures suggest that the company is generating solid returns for its shareholders and effectively utilizing its asset base to generate income.
The company's revenue is primarily concentrated in the pharmaceutical segment, with no disclosed geographic breakdown. This concentration may expose the company to specific market risks, such as regulatory changes or shifts in demand within the pharmaceutical industry. However, the lack of geographic diversification data makes it difficult to assess the extent of such risks.
Looking ahead, the company is expected to maintain a stable growth trajectory. Analysts have provided a mean price target of 44.81 CNY, with a median of 45.63 CNY, indicating a generally positive outlook. The mean recommendation of 2.60 suggests a mixed sentiment among analysts, with a slight lean towards a buy rating. The company's revenue history and current financial health support this outlook.
Risk factors for the company include a medium liquidity risk and a low dilution risk. The company has a negative net cash position after subtracting total debt, which could affect its ability to meet short-term obligations. However, the low dilution risk indicates that the company is not expected to issue additional shares in the near term, preserving shareholder value.
Recent events and filings have not been disclosed in the provided data, so it is unclear if there have been any significant developments that could impact the company's operations or financial performance. Investors should monitor any new filings or announcements for potential insights into the company's future direction.
- Topchoice Medical Co Inc has a strong ROE of 11.86% and ROA of 8.31%, indicating efficient use of equity and assets.
- The company's debt-to-equity ratio of 0.26 suggests a conservative capital structure with low debt reliance.
- Analysts have a generally positive outlook, with a mean price target of 44.81 CNY and a median of 45.63 CNY.
- The company's liquidity position is medium, with a current ratio of 1.49, indicating adequate but not excessive short-term liquidity.
- The company has a low dilution risk, suggesting no immediate threat to shareholder value from new share issuance.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 1,27 |
| Revenue | —no estimate | —no estimate | 3,3B CNY |
| Operating income | —no estimate | —no estimate | 776,6M CNY |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Topchoice Medical Co Inc Market data — financials · 2026-05-27
- Topchoice Medical Co Inc Market data — analyst estimates · 2026-05-27
- Topchoice Medical Co Inc Market data — ESG · 2026-05-27